Search

Search Results

1. High Grade Differentiated Follicular Cell-Derived Thyroid Carcinoma Versus Poorly Differentiated Thyroid Carcinoma: A Clinicopathologic Analysis of 41 Cases

   Criteria overlap for separating between malignant follicular epithelial cell-derived thyroid gland neoplasms with high grade features of increased...

   Lester D. R. Thompson in Endocrine Pathology

   Article 17 May 2023
   

2. Poorly differentiated papillary thyroid carcinoma in a 5-year-old girl: a case report

   Background

   The incidence of thyroid cancer has been increasing among the population less than 20 years of age, especially during the second decade of...

   Mohanned Mohsen, Omar Hamdy, ... Mohamed Ezat in Egyptian Pediatric Association Gazette

   Article Open access 26 February 2024
   

3. Impact of age on tumor characteristics and treatment outcomes in pediatric Differentiated Thyroid Carcinoma

   Purpose

   There is a tendency to use data generated for adults in the management of pediatric Differentiated Thyroid Carcinoma, neglecting the clinical...

   Juliana Chaves Garcia, Ligia Vera Montali de Assumpção, ... Denise Engelbrecht Zantut-Wittmann in Endocrine

   Article 15 May 2024

4. Current evidences in poorly differentiated thyroid carcinoma: a systematic review and subsection meta-analysis for clinical decision making

   Background

   Poorly differentiated thyroid carcinoma (PDTC) is a distinct entity with intermediate prognosis between indolent follicular thyroid cancers...

   Sataksi Chatterjee, Manish Mair, ... Anil Keith D’Cruz in Endocrine

   Article 19 March 2024
   

5. First Hit the Best Hit for Advanced Differentiated Papillary Thyroid Carcinoma?

   Optimal upfront surgery with precise and objective image map** is perhaps the way to go to enhance treatment outcomes and mitigate the use of...

   Bipin T. Varghese in Indian Journal of Surgical Oncology

   Article 15 June 2024

6. Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma

   Background

   The 2015 American Thyroid Association (ATA) guidelines proposed the use of the ATA Risk Stratification System and American Joint Committee...

   **wen Wang, Yaqian Mao, ... Jun** Wen in Endocrine

   Article 29 May 2024
   

7. Neoadjuvant Multikinase Inhibitor Therapy in Locally Advanced Unresectable Differentiated Thyroid Carcinoma: a Case Report

   Multikinase or tyrosine kinase inhibitors (TKI) are currently approved for radioiodine-refractory metastatic differentiated thyroid carcinoma...

   Vikram Sharanappa, Sushobhan Pradhan, ... Prasanta Kumar Pradhan in Indian Journal of Surgery

   Article 14 December 2022
   

8. Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report 

   Background

   Malignant struma ovarii is a very rare type of gynecologic cancer. Although its most common histological subtype is a pure type of...

   Nao Terayama, Satoe Fujiwara, ... Masahide Ohmichi in Journal of Medical Case Reports

   Article Open access 30 September 2022
   

9. Active surveillance of nodal metastasis in differentiated thyroid carcinoma: a systematic review and meta-analysis

   Purpose

   Cervical lymph nodes (LN) represent the most common site of recurrence in differentiated thyroid cancer (DTC), frequently requiring repeated...

   Anita Lavarda Scheinpflug, Laura Marmitt, ... Ana Luiza Maia in Endocrine

   Article 07 May 2024
   

10. Radioiodine whole body scan pitfalls in differentiated thyroid cancer

    Purpose

    whole body scan (WBS) performed following diagnostic or therapeutic administration of I-131 is useful in patients with differentiated thyroid...

    Cristina Basso, Alessandra Colapinto, ... Andrea Repaci in Endocrine

    Article 18 March 2024
    

11. Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status

    Purpose

    Risk factors for develo** radioiodine refractory thyroid cancer (RAIR-TC) have rarely been analyzed. The purpose of the present study was to...

    L. Schubert, A. M. Mbekwe-Yepnang, ... C. Buffet in Journal of Endocrinological Investigation

    Article Open access 05 April 2024
    

12. Significance of oncocytic features in poorly differentiated thyroid carcinoma — a bi-institutional experience

    Poorly differentiated thyroid carcinoma (PDTC), defined by Turin criteria, comprises a subset of high-grade follicular-derived thyroid carcinomas...

    Bin Xu, Daniel J. Lubin, ... Kartik Viswanathan in Virchows Archiv

    Article 08 November 2022
    

13. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms

    Background

    Columnar cell papillary thyroid carcinoma (CC-PTC) is a morphologic subtype of papillary thyroid carcinoma with a variable prognosis. It is...

    Kathleen E. Higgins, Peter M. Sadow, ... Nicole A. Cipriani in Head and Neck Pathology

    Article 10 May 2024
    

14. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas

    Poorly differentiated thyroid carcinoma (PDTC) and high-grade differentiated thyroid carcinoma (HGDTC) are considered high-grade follicular-derived...

    Vincent Cracolici, Nicole A. Cipriani in Endocrine Pathology

    Article 24 January 2023
    

15. Wide Composite Resection of Sternal Metastasis & Reconstruction Using Titanium Mesh Implant and Myocutaneous Flap in Differentiated Thyroid Carcinoma: Case Report of Two Cases

    Differentiated Thyroid carcinoma (DTC) with distant skeletal metastases is associated with a very poor prognosis and are unfortunately resistant to...

    Mit Rojesara, Swati Sattavan, ... Senthil Kumar M in Indian Journal of Otolaryngology and Head & Neck Surgery

    Article 10 November 2023
    

16. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience

    Differentiated high-grade thyroid carcinoma (DHGTC) is a new entity in the 2022 WHO classification. We aimed to investigate the incidence and...

    Se In Jeong, Woochul Kim, ... Hee Young Na in Endocrine Pathology

    Article 29 July 2023
    

17. Comparison of endoscopic bilateral areolar and robotic-assisted bilateral axillo-breast approach thyroidectomy in differentiated thyroid carcinoma: a propensity-matched retrospective cohort study

    Background

    Robot-assisted and endoscopic thyroidectomy are superior to conventional open thyroidectomy in improving cosmetic outcomes and...

    **aokang Fu, Yunhan Ma, ... Luming Zheng in BMC Surgery

    Article Open access 08 November 2023
    

18. Differentiated Thyroid Cancers with Synchronous Second Primary Cancers: Case Series

    The incidence of synchronous second primary cancer (SSPC) with DIfferentiated Thyroid Cancers (DTC) is a very rare entity. Very few case reports and...

    Devarajan Jebin Aaron, Priyank Rathod, ... Shashank Pandya in Indian Journal of Otolaryngology and Head & Neck Surgery

    Article 09 May 2024
    

19. Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact

    Poorly differentiated thyroid carcinomas (PDTC) are rare diseases; nevertheless, they account for the majority of deaths from non-anaplastic...

    Andrés Coca-Pelaz, Juan P. Rodrigo, ... Alfio Ferlito in Virchows Archiv

    Article 24 February 2024
    

20. Dynamic risk assessment in patients with differentiated thyroid cancer

    The current approach for patients with differentiated thyroid carcinoma should be individualized according to the risk of recurrence, and this...

    Erika Abelleira, Fernando Jerkovich in Reviews in Endocrine and Metabolic Disorders

    Article 28 November 2023